APN inhibitor 4cc also synergizes the antitumor effects of 5FU in human liver cancer cells via ROS-mediated drug resistance inhibition and concurrent activation of the mitochondrial pathways of apoptosis (Sun et al., 2015). The gene discussed is ANPEP; the disease is liver cancer.